May, 09 2019 12:33 JST
Eisai and Allm Enter Into Capital and Business Alliance Agreement for ICT Healthcare Solutions
TOKYO, May, 09 2019 - (JCN Newswire) - Eisai Co., Ltd. and Allm Inc. have entered into a capital and business alliance agreement for ICT digital health solutions in various areas as well as regional medical treatment and care. Under this capital and business alliance, the two companies will collaborate on information provision to patients and healthcare professionals as well as development and provision of digital health solutions in regional medical treatment cooperation and comprehensive community care by extensively utilizing Allm's ICT systems for medical treatment and care. By applying Allm's experience in medical ICT systems to the "Dementia Ecosystem" that Eisai aims to establish, the two companies will thoroughly promote the utilization of IoT, big data and AI technologies in the health care area and provide new value for patients under the Fourth Industrial Revolution.
In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), promoting various kinds of digitalization such as the analysis of big data including real world data for the development of diagnostic methods and the provision of solutions in addition to creating next-generation treatment primarily in "neurology" and "oncology" that are Eisai's therapeutic areas of focus. Especially in the area of dementia, Eisai aims to establish the "Eisai Dementia Platform" by actively utilizing external big data and genomic data in addition to Eisai's own experience, know-how, and clinical data as well as build the "Dementia Ecosystem" by collaborating with partners such as other pharmaceutical companies, governments, medical organizations, care facilities, diagnostic developing companies, IT companies and insurance companies. Eisai thus aims to deliver novel benefits to patients with dementia and their families.
As "a company supporting all medicines (All Medical)", Allm upholds "Shaping Healthcare" as its corporate message, and provides services making contributions to the creation of global, social welfare design through IT technology. As a venture company specialized in medicine and healthcare, Allm is engaged in the development of programs for medical devices and provides "Team" comprehensive community care application and "MySOS" personal health record app. Currently operating in 12 countries, the company internationally provides approximately 1,700 medical/nursing institutions with ICT systems for medicine and nursing. In particular, the "Join" communication app for communication among healthcare professionals has become Japan's first medical device program which was made eligible for national health insurance by the Central Social Insurance Medical Council of the Japanese Ministry of Heath, Labor and Welfare.
Through these efforts to coordinate on the provision of healthcare solutions using ICT and the establishment of ecosystems in the area of dementia and others, Eisai and Allm are working to solve issues in regional medical treatment and care, and therefore contribution to the realization of well-being.
About Allm Inc.
As a "company supporting all medicines (All Medical)" upholding "Shaping Healthcare" as its corporate message, Allm provides mobile ICT solutions in the area of medicine and welfare. The company also proactively approaches global deployment of medical ICT business including the "Join" app for communication among healthcare professionals, providing solutions in 12 countries as a Japanese medical ICT company.
For more information about Allm Inc., please visit https://www.allm.net.
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.
In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.
For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.
Group Strategy Office
Eisai Co., Ltd.
Public Relations Department
Copyright ©2019 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
More Latest Release >>
MITSUBISHI MOTORS' eK X & eK Wagon Kei Cars Win RJC Car of the Year 2020
Nov 13, 2019 19:39 JST
MHI Aero Engines Makes First Shipment of Domestically Assembled Pratt & Whitney GTF PW1200G Engine for the Mitsubishi SpaceJet
Nov 13, 2019 16:01 JST
Fujitsu Launches New PRIMEHPC Supercomputers Using Fugaku Technology
Nov 13, 2019 10:37 JST
Cray and Fujitsu Partner to Power Supercomputing in the Exascale Era
Nov 13, 2019 10:02 JST
MITSUBISHI MOTORS Introduces XPANDER CROSS
Nov 12, 2019 18:01 JST
DENSO Recognized with "Friend of ASEAN Award" at the ASEAN Business Awards (ABA) 2019
Nov 11, 2019 17:07 JST
Lexus Electric Debuts in China
Nov 11, 2019 16:38 JST
Fujitsu Expands Mid-career Recruitment
Nov 11, 2019 10:33 JST
Double Shanghai Podium for TOYOTA GAZOO Racing
Nov 11, 2019 09:11 JST
TOYOTA GAZOO Racing goes all-in for another title in Australia
Nov 08, 2019 19:33 JST
Honda Releases Consolidated Financial Summary for the Fiscal 2nd Quarter Ended September 30, 2019
Nov 08, 2019 15:09 JST
Mitsubishi Model A Selected as Historic Car by JAHFA
Nov 08, 2019 14:49 JST
BYD, Toyota Agree to Establish Joint Company for Battery Electric Vehicle Research and Development
Nov 07, 2019 19:12 JST
MITSUBISHI MOTORS Restyles Mirage and Attrage Compact Models
Nov 07, 2019 11:58 JST
Hitachi and Centre Leon Berard Cancer Center in Lyon to Launch a Research Collaboration in the Fight Against Cancer with AI
Nov 07, 2019 07:25 JST
Fujitsu Improves Efficiency in Cancer Genomic Medicine in Joint AI Research with the Institute of Medical Science at the University of Tokyo
Nov 07, 2019 05:09 JST
ULVAC launches Smartphone-Direct Pirani Gauge "SWU10-U"
Nov 06, 2019 17:00 JST
Showa Denko (SDK) Announces 2019 Third Quarter Financial Results
Nov 06, 2019 16:00 JST
NEC Showcases Industry-leading Digital Finance Solutions at Inaugural SFF X Switch 2019
Nov 06, 2019 15:11 JST
Suzhou Tongji Blockchain Research Institute and Fujitsu Research and Development Center start Research Collaboration on Blockchain Technology
Nov 06, 2019 11:45 JST